Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA Gains 10%; BSE HEALTHCARE Index Up 0.3%
Tue, 13 Aug 9:18

ASTRAZENECA PHARMA Gains 10%; BSE HEALTHCARE Index Up 0.3%Image source: Sakorn BernardaSv/www.istockphoto.com

ASTRAZENECA PHARMA share price has zoomed 10% and is presently trading at Rs 6,873.6.

Meanwhile, the BSE HEALTHCARE index is at 41,184.9 (up 0.3%).

Among the top gainers in the BSE HEALTHCARE index today are POLY MEDICURE (up 2.9%) and Natco Pharma (up 2.0%).

SYNGENE INTERNATIONAL (down 1.9%) and SUVEN PHARMACEUTICALS (down 1.8%) are among the top losers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 3,810.3 to Rs 6,873.6, registering a gain of Rs 3,063.3 (up 80.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,485.8 to 41,184.9, registering a gain of 44.6% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 114.7%), Jubilant Pharmova (up 110.6%) and SUVEN PHARMACEUTICALS (up 103.4%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 79,552.5 (down 0.1%).

The top losers among the BSE Sensex today are HDFC Bank (down 2.0%) and Power Grid Corp. (down 0.9%). The most traded stocks in the BSE Sensex are Tata Steel and HDFC Bank.

In the meantime, NSE Nifty is at 24,342.4 . HDFC Bank and Power Grid Corp. are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,995.8 to 79,552.5, registering a gain of 13,556.7 points (up 20.5%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit fell 121.9% YoY to Rs -118 million for the quarter ended June 2024, compared to a profit of Rs 539 million a year ago. Net sales rose 31.2% to Rs 3,875 million during the period as against Rs 2,955 million in April-June 2023.

For the year ended March 2024, ASTRAZENECA PHARMA reported 62.7% increase in net profit to Rs 1,615 million compared to net profit of Rs 993 million during FY23. Revenue of the company grew 29.2% to Rs 12,955 million during FY24.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 179.3.


Equitymaster requests your view! Post a comment on "ASTRAZENECA PHARMA Gains 10%; BSE HEALTHCARE Index Up 0.3%". Click here!